[
  {
    "ts": "2025-10-22T21:50:05+00:00",
    "headline": "Moderna (MRNA) Dips More Than Broader Market: What You Should Know",
    "summary": "Moderna (MRNA) closed at $26.85 in the latest trading session, marking a -2.33% move from the prior day.",
    "url": "https://finance.yahoo.com/news/moderna-mrna-dips-more-broader-215005931.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "026cc3a0-4236-3d70-9545-8b7b65c93dc9",
      "content": {
        "id": "026cc3a0-4236-3d70-9545-8b7b65c93dc9",
        "contentType": "STORY",
        "title": "Moderna (MRNA) Dips More Than Broader Market: What You Should Know",
        "description": "",
        "summary": "Moderna (MRNA) closed at $26.85 in the latest trading session, marking a -2.33% move from the prior day.",
        "pubDate": "2025-10-22T21:50:05Z",
        "displayTime": "2025-10-22T21:50:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a",
          "originalWidth": 900,
          "originalHeight": 476,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5btkEdScc6bMd.LwAmujVg--~B/aD00NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a.cf.webp",
              "width": 900,
              "height": 476,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PSL6wqVlNgtKuHixyahWwA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/moderna-mrna-dips-more-broader-215005931.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-mrna-dips-more-broader-215005931.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-22T20:23:00+00:00",
    "headline": "Moderna says CMV vaccine once seen as future blockbuster fails key study",
    "summary": "A shot analysts projected as a multibillion-dollar seller produced results “well below” the company’s expectations, heightening pressure on Moderna’s flagging respiratory vaccine business.",
    "url": "https://www.biopharmadive.com/news/moderna-cytomegalovirus-vaccine-study-failure/803560/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "586f1b57-8d8d-3677-a8b9-798f8a92c79a",
      "content": {
        "id": "586f1b57-8d8d-3677-a8b9-798f8a92c79a",
        "contentType": "STORY",
        "title": "Moderna says CMV vaccine once seen as future blockbuster fails key study",
        "description": "",
        "summary": "A shot analysts projected as a multibillion-dollar seller produced results “well below” the company’s expectations, heightening pressure on Moderna’s flagging respiratory vaccine business.",
        "pubDate": "2025-10-22T20:23:00Z",
        "displayTime": "2025-10-22T20:23:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/b46d5df9e76d8a9995c0e3656a122abf",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "The Moderna headquarters is seen on November 30, 2020 in Cambridge, Massachusetts.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MsgwCNJDC_TMhH72dAtRxQ--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/b46d5df9e76d8a9995c0e3656a122abf.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xVqgJOhi9wHK6RodnIRBpg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/b46d5df9e76d8a9995c0e3656a122abf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/moderna-cytomegalovirus-vaccine-study-failure/803560/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-says-cmv-vaccine-once-202300607.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-22T20:05:00+00:00",
    "headline": "Moderna Drops Vaccine for Birth Defects After Trial Failure",
    "summary": "Moderna  is stopping development of a vaccine designed to prevent birth defects caused by cytomegalovirus, or CMV, once among its most-watched experimental programs.  CMV infections generally don’t cause symptoms in adults, but babies who contract the virus during pregnancy can suffer long-term health effects.  The Moderna jab would have needed to fully prevent infections in pregnant mothers, not just tamp down symptoms, to protect infants from birth defects.",
    "url": "https://www.barrons.com/articles/moderna-stock-vaccine-birth-defects-73b15a9e?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "7a242d7a-987d-390e-9ddb-07706fbbbc0a",
      "content": {
        "id": "7a242d7a-987d-390e-9ddb-07706fbbbc0a",
        "contentType": "STORY",
        "title": "Moderna Drops Vaccine for Birth Defects After Trial Failure",
        "description": "",
        "summary": "Moderna  is stopping development of a vaccine designed to prevent birth defects caused by cytomegalovirus, or CMV, once among its most-watched experimental programs.  CMV infections generally don’t cause symptoms in adults, but babies who contract the virus during pregnancy can suffer long-term health effects.  The Moderna jab would have needed to fully prevent infections in pregnant mothers, not just tamp down symptoms, to protect infants from birth defects.",
        "pubDate": "2025-10-22T20:05:00Z",
        "displayTime": "2025-10-22T20:05:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/7a242d7a-987d-390e-9ddb-07706fbbbc0a/moderna-drops-vaccine-for.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/01fe31e630a4d8a097a27aa181dee661",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9q10Vg4ihKfn4IC8IHWSmA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/01fe31e630a4d8a097a27aa181dee661.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fPiBrN071kDBM9Th2bJz3Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/01fe31e630a4d8a097a27aa181dee661.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/moderna-stock-vaccine-birth-defects-73b15a9e?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-22T20:05:00+00:00",
    "headline": "Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint",
    "summary": "Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing Phase 2 trial in bone marrow transplant patients Company does not anticipate any impact to its 2025 financial guidance or its ...",
    "url": "https://finance.yahoo.com/news/moderna-announces-phase-3-study-200500174.html",
    "source": "ACCESS Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "849ebfa0-649b-3da6-8c50-c06e6d348774",
      "content": {
        "id": "849ebfa0-649b-3da6-8c50-c06e6d348774",
        "contentType": "STORY",
        "title": "Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint",
        "description": "",
        "summary": "Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing Phase 2 trial in bone marrow transplant patients Company does not anticipate any impact to its 2025 financial guidance or its ...",
        "pubDate": "2025-10-22T20:05:00Z",
        "displayTime": "2025-10-22T20:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/accesswire.ca/2233b456baebcb9b5dcb57d6eaa868ac",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "<![CDATA[Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing Phase ...]]>",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Y14NrymWnVHtLPxT5mPm5g--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/2233b456baebcb9b5dcb57d6eaa868ac.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dSewxxG3XkMHQTa3gmVr6w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/2233b456baebcb9b5dcb57d6eaa868ac.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "ACCESS Newswire",
          "url": "https://www.accessnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/moderna-announces-phase-3-study-200500174.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-announces-phase-3-study-200500174.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "META"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-22T17:10:00+00:00",
    "headline": "Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.",
    "summary": "The biotech's innovative qualities will come in handy.",
    "url": "https://www.fool.com/investing/2025/10/22/prediction-moderna-will-soar-over-the-next-5-years/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "2fba00a8-fd05-3992-b627-5ee1bc22d546",
      "content": {
        "id": "2fba00a8-fd05-3992-b627-5ee1bc22d546",
        "contentType": "STORY",
        "title": "Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.",
        "description": "",
        "summary": "The biotech's innovative qualities will come in handy.",
        "pubDate": "2025-10-22T17:10:00Z",
        "displayTime": "2025-10-22T17:10:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/74e5d6507624b80513d9b28bedc5b0e9",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Person in business dress working on one of several computers in a dimly lit office.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3U4FjOU7dLEULYHEAKaK_w--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/74e5d6507624b80513d9b28bedc5b0e9.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8lv4ZKy_PcHD5zPn0srn9Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/74e5d6507624b80513d9b28bedc5b0e9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/22/prediction-moderna-will-soar-over-the-next-5-years/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/prediction-moderna-soar-over-next-171000260.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-22T15:12:33+00:00",
    "headline": "Stock Market Today: Tesla and IBM Tumble After Earnings; Moderna Trial Misses",
    "summary": "This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Wednesday. This is TheStreet’s Stock Market Today for Oct. 22, 2025. You can follow the latest updates on the ...",
    "url": "https://www.thestreet.com/markets/stock-market-today-stocks-decline-as-earnings-season-picks-up-pace",
    "source": "TheStreet",
    "provider": "yfinance",
    "raw": {
      "id": "a12f3cc1-3e9e-312e-b2fd-2e05049a274f",
      "content": {
        "id": "a12f3cc1-3e9e-312e-b2fd-2e05049a274f",
        "contentType": "STORY",
        "title": "Stock Market Today: Tesla and IBM Tumble After Earnings; Moderna Trial Misses",
        "description": "",
        "summary": "This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Wednesday. This is TheStreet’s Stock Market Today for Oct. 22, 2025. You can follow the latest updates on the ...",
        "pubDate": "2025-10-22T15:12:33Z",
        "displayTime": "2025-10-22T15:12:33Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/thestreet_881/29543518ee7bccb5ef0f3e346fa1f4bf",
          "originalWidth": 1200,
          "originalHeight": 800,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nNP.61wPtYsH1nvyAn6Gdg--~B/aD04MDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/thestreet_881/29543518ee7bccb5ef0f3e346fa1f4bf.cf.webp",
              "width": 1200,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JgwjbogobZal9Mfq2dqhQA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/thestreet_881/29543518ee7bccb5ef0f3e346fa1f4bf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TheStreet",
          "url": "https://www.thestreet.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thestreet.com/markets/stock-market-today-stocks-decline-as-earnings-season-picks-up-pace",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stock-market-today-stocks-decline-151233569.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IBM"
            },
            {
              "symbol": "LUV"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-22T13:53:00+00:00",
    "headline": "Should You Buy Moderna Right Now?",
    "summary": "Shares could keep sliding, as Moderna's post-COVID pipeline has yet to reach a breakthrough.",
    "url": "https://www.fool.com/investing/2025/10/22/should-you-buy-moderna-right-now/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "ff6d7b03-b4dd-333f-917f-c26b51143514",
      "content": {
        "id": "ff6d7b03-b4dd-333f-917f-c26b51143514",
        "contentType": "STORY",
        "title": "Should You Buy Moderna Right Now?",
        "description": "",
        "summary": "Shares could keep sliding, as Moderna's post-COVID pipeline has yet to reach a breakthrough.",
        "pubDate": "2025-10-22T13:53:00Z",
        "displayTime": "2025-10-22T13:53:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/fe601b4dab5210550f7d029f2dae362d",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A pair of biotech researchers discuss their findings.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rw7t8heiS2B0j.IxW7.g.A--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/fe601b4dab5210550f7d029f2dae362d.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/X0e35Wu8M56NHJmX7qz77A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/fe601b4dab5210550f7d029f2dae362d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/22/should-you-buy-moderna-right-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-moderna-now-135300262.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]